You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Metastatic Pathologic Fractures, Short Term Results

Recruiting
  • Pathologic Fracture
  • +2 more
  • endoprosthetic reconstruction
  • +2 more
  • Ankara, Altindag, Turkey
    Ankara University Medical Faculty
Apr 11, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

    Active, not recruiting
    Has Results
    • Metastatic Non-small Cell Lung Cancer
    • Metastatic Triple-negative Breast Cancer
    • ADV/HSV-tk
    • +3 more
    • Houston, Texas
      Houston Methodist Cancer Center
    Dec 28, 2022

    Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jul 12, 2023

    Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

    Completed
    • Metastatic Colorectal Adenocarcinoma
    • regorafenib plus anti-PD-1 antibodies
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Jul 4, 2023

    Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Cetuximab and irinotecan
    • (no location specified)
    Jul 26, 2023

    Baseline Metastases on Clinical Outcomes Among BRAF Positive

    Completed
    • BRAF Positive Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis
      Aug 2, 2023

      Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)

      Not yet recruiting
      • Metastatic Solid Tumors
      • Advanced Solid Tumors
      • (no location specified)
      May 2, 2023

      HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

      Not yet recruiting
      • HER2-PositiveRecurrent or Metastatic Breast Cancer
      • SHR-A1811 Injection
      • +2 more
      • (no location specified)
      Sep 21, 2023

      Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

      Recruiting
      • Metastatic Cancer
      • +5 more
      • Written Exposure Therapy
      • Boulder, Colorado
        University of Colorado Boulder
      Sep 13, 2023

      Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

      Recruiting
      • Pheochromocytoma, Metastatic
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      May 31, 2023

      Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

      Not yet recruiting
      • Metastatic Pancreatic Cancer
      • Washington, District of Columbia
        Lombardi Comprehensive Cancer Center, Georgetown University
      Aug 24, 2023

      Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +

      Not yet recruiting
      • Colorectal Cancer
      • Metastatic Colon Cancer
      • Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
      • Placebo + FOLFIRI + Bevacizumab
      • (no location specified)
      Aug 1, 2023

      Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

      Not yet recruiting
      • Pancreatic Adenocarcinoma Metastatic
        • Pessac, France
          CHU Bordeaux
        Aug 17, 2023

        Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

        Recruiting
        • Unresectable/Metastatic Colorectal Cancer
        • Fruquintinib plus camrelizumab and capecitabine
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital, Sun Yat-sen University
        Nov 19, 2023

        Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

        Recruiting
        • Advanced Ovarian Carcinoma
        • +7 more
        • Bydgoszcz, Kujawsko-pomorskie, Poland
        • +2 more
        Mar 7, 2023

        Adverse Events, Produced by Antibodies Conjugates, on Quality of

        Not yet recruiting
        • Metastatic Breast Cancer
          • Aviano, Pordenone, Italy
          • +2 more
          Oct 24, 2023

          Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

          Not yet recruiting
          • Pancreatic Cancer Metastatic
          • Pancreatic Adenocarcinoma Metastatic
          • Scottsdale, Arizona
            Clinical Trials Nurse Navigator
          Oct 3, 2023

          Solid Tumor Trial (DR30206)

          Not yet recruiting
          • Solid Tumor
          • (no location specified)
          Nov 14, 2023

          Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

          Recruiting
          • Cancer
          • +11 more
          • San Antonio, Texas
            South Texas Accelerated Research Therapeutics, LLC
          Jun 21, 2023

          Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

          Not yet recruiting
          • Unresectable Metastatic Colorectal Cancer
          • (no location specified)
          Oct 25, 2023

          Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

          Not yet recruiting
          • Cervical Cancer
          • (no location specified)
          Sep 9, 2023